Rapid and high throughput assessment of cellular immunity against SARS-CoV-2 based on the ex vivo activation of genes in leukocyte assay with whole blood.

Rapid and high throughput assessment of cellular immunity against SARS-CoV-2 based on the ex vivo activation of genes in leukocyte assay with whole blood.

Publication date: Jan 29, 2024

Concepts Keywords
Biophys Cellular immunity
Coronaviruses Coronavirus disease 2019
Covid Leukocyte
Immune T-cell
Vaccine

Semantics

Type Source Name
disease IDO assay
disease VO vaccine
disease MESH infection
disease IDO cell
disease MESH SARS-CoV-2 infection
pathway REACTOME SARS-CoV-2 Infection
disease IDO blood
disease VO vaccinated
disease MESH viral infection

Original Article

(Visited 1 times, 1 visits today)